Stock Events

Stock Events

Bioton. 

€0.93
6
+€0.01+0.65% Tuesday 19:33

Statistics

Day High
0.95
Day Low
0.92
52W High
0.96
52W Low
0.92
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

30OctExpected
Q3 2025
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 7U5.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novo Nordisk
NVO
Mkt Cap194.57B
Novo Nordisk is a leading global healthcare company that also specializes in diabetes care, directly competing with Bioton in the insulin market.
Sanofi
SNY
Mkt Cap110.4B
Sanofi produces insulin and other diabetes treatments, competing directly in the same therapeutic areas as Bioton.
Lilly(Eli) &
LLY
Mkt Cap862.01B
Eli Lilly is a major player in the production of insulin and diabetes care products, positioning it as a direct competitor to Bioton.
Merck
MRK
Mkt Cap277.02B
Merck & Co., known for its wide range of pharmaceutical products, including diabetes care, competes in the same market as Bioton.
Novartis
NVS
Mkt Cap279.67B
Novartis is involved in the manufacture of drugs that treat various chronic diseases, including diabetes, competing with Bioton's products.
Astrazeneca
AZN
Mkt Cap286.4B
AstraZeneca produces several diabetes medications, making it a competitor in the diabetes care market where Bioton operates.
Takeda Pharmaceutical
TAK
Mkt Cap52.51B
Takeda Pharmaceutical Company provides a range of healthcare solutions including diabetes care, competing in the same space as Bioton.
Abbott Laboratories
ABT
Mkt Cap155.82B
Abbott Laboratories, while known for a broader range of medical devices and diagnostics, also competes in the diabetes care market affecting Bioton's business.

About

BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally. The company offers recombinant human insulin; oral diabetic drugs; strips for measuring sugar in blood, as well as Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes monitoring technology, as well as needles. BIOTON S.A. was founded in 1989 and is based in Ozarów Mazowiecki, Poland.
Show more...
CEO
Mr. Jeremy Launders
Employees
361
Country
Germany
ISIN
PLBIOTN00029

Listings

STU
DE
7U5.STU
F
DE
7U5.F
WA
PL
BIO.WA
LSE
GB
0DTR.LSE

0 Comments

Share your thoughts

FAQ

What is Bioton. stock price today?▼
The current price of 7U5.STU is €0.93 EUR — it has increased by +0.65% in the past 24 hours. Watch Bioton. stock price performance more closely on the chart.
What is Bioton. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Bioton. stocks are traded under the ticker 7U5.STU.
How many employees does Bioton. have?▼
As of May 06, 2026, the company has 361 employees.
In which sector is Bioton. located?▼
Bioton. operates in the Health & Wellness sector.
When did Bioton. complete a stock split?▼
Bioton. has not had any recent stock splits.
Where is Bioton. headquartered?▼
Bioton. is headquartered in Ozarów Mazowiecki, Germany.